Recent improvement of survival after breast cancer in Switzerland

Similar documents
Zurich Open Repository and Archive. Variation in survival after diagnosis of breast cancer in Switzerland

CLINICAL-PATHOLOGICAL INDICATORS OF AN OPPORTUNISTIC BREAST CANCER SCREENING: A POPULATION-BASED STUDY

NICER. Trends in Prostate Cancer Survival in Switzerland

Introduction Cancer is a major public health threat in Switzerland.

Estimating relative survival using the strel command

NICER. Trends in survival from oesophageal cancer in Switzerland

NICER. Trends in Pancreatic Cancer Survival in Switzerland

Downloaded from:

Inequalities in cancer survival: Spearhead Primary Care Trusts are appropriate geographic units of analyses

periodr an R package to calculate long term cancer survival estimates using period analysis

NICER. Survival Trends for Kidney Cancer Patients in Switzerland. Introduction. Methods

Period estimates of cancer patient survival are more up-to-date than complete estimates even at comparable levels of precision

Cancer prevalence in Central Europe: the EUROPREVAL Study

An Overview of Survival Statistics in SEER*Stat

Model-free machine learning methods for personalized breast cancer risk prediction -SWISS PROMPT

Swiss Federal Office of Public Health

Analysing population-based cancer survival settling the controversies

Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy

R. Schaffar 1*, A. Belot 2, B. Rachet 2 and L. Woods 2

Age-standardised Net Survival & Cohort and Period Net Survival Estimates

A population-based study on the patterns of use of different chemotherapy regimens in patients with early breast cancer

CANCER OVER THE AGES: GERIATRISCHE TUMOREN

Survival in Teenagers and Young. Adults with Cancer in the UK

Swiss Cancer Report Current situation and developments. Health Neuchâtel 2016

Cannabis monitoring in Switzerland:

BREAST CANCER IN YOUNG WOMEN: OCTOBER 9 th 2015 Aula Magna UNIVERSITÀ DELLA SVIZZERA ITALIANA Lugano

Volker Arndt, MD, MPH National Institute for Cancer Epidemiology and Registration (NICER) Zurich

Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results

External radiotherapy increases the risk of death from early stage endometrial cancer

Estimating the Current and Future Burden of Cancer in Canada: Identifying Opportunities for Prevention

NICER. Incidence-based Mortality Trends for Thyroid Cancer: Is there a «true» Increase in Incidence of Thyroid Cancer in Switzerland?

Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy

Indicators of data quality at the Cancer Registry Zurich and Zug in Switzerland

Strategies for data analysis: case-control studies

Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium

CARDIOVASCULAR RESEARCH MEETING March 2018 University of Fribourg, Campus de Pérolles SPONSORSHIP BOOKLET

National Cancer Statistics in Korea, 2014

Deprivation and Cancer Survival in Scotland: Technical Report

Epidemiology and outcome research of glioma patients in Southern Switzerland: A population based analysis

EFORT Instructional Course

SEER 2014 TNM Training Needs Assessment Study

Downloaded from:

NICER. Age-dependent risk and lifetime risk of developing cancer in Switzerland

Table 2.6. Cohort studies of HCV and lymphoid malignancies

Major differences in diet across 3 linguistic regions of Switzerland

NICER Core Dataset (NCD) Abbreviated Online Version

ORIGINAL RESEARCH. Open Access. Abstract

Preliminary Program. SAKK Semi-Annual Meeting November 22 & 23. Zurich Marriott Hotel Neumühlequai 42, 8006 Zurich

Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland

One week Course in Implant Dentistry

Schweizer Register für Neuroendokrine Tumore Le Registre Suisse des tumeurs neuroendocrines Registro Svizzero per i Tumori Neuroendocrini

NICER. Lung Cancer Trends by Histologic Subtype in Switzerland

Annual Report 2009/2010

J Clin Oncol 24: by American Society of Clinical Oncology INTRODUCTION

Incidence, mortality and survival of female breast cancer during in Jiangsu province, China

AN EMPIRICAL EVALUATION OF PERIOD SURVIVAL ANALYSIS USING DATA FROM THE CANADIAN CANCER REGISTRY. Larry F. Ellison MSc, Statistics Canada

Program. SAKK Semi-Annual Meeting November 23 & 24. Zurich Marriott Hotel Neumühlequai 42, 8006 Zurich

BREAST AUGMENTATION IMPLANTS AND FAT

Meta-analysis of IDH-mutant cancers identifies EBF1 as a novel interaction partner for

Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007

GENERAL ICD- C61: Prostate cancer Page 2 of 18 ICD- C61: Malignant neoplasm of prostate Period of diagnosis % Relative survival N=46,

Monitoring Cancer in Switzerland and Europe

Breast and Colorectal Cancer mortality. in Scotland can we do better?

Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden

Estimating and Modelling the Proportion Cured of Disease in Population Based Cancer Studies

Changing patterns of cancer incidence in the early- and late-haart periods: the Swiss HIV Cohort Study

Extension to medium and low risk patients? Friedrich Eckstein University Hospital Basel

Vincent Y. F. He 1*, John R. Condon 1, Peter D. Baade 1,2, Xiaohua Zhang 3 and Yuejen Zhao 3

Admissions of patients with alcohol intoxication in the Emergency Department: a growing phenomenon

Wintermeeting Swiss Working Group «Interventional Cardiology» January 22 nd - 23 rd, Grand Hôtel Suisse Majestic Montreux

Swiss survey on salt intake: main results

Diploma course of the Swiss Society of Senology (SSS)

What we know and what we don't know about early-developmental support and education of DHH children in five European countries

Validation of a 10-year Mortality Index for Community-Dwelling Older Adults

Fundamentals in Vascular Surgery

EPOS BAT ADVANCED COURSE. Hip surgery from infancy to young adulthood ORTHOPEDICS

23rd Trauma Course AIOD - OTC Suisse

Downloaded from:

Introduction. Ruoran Li 1 Rhian Daniel

Kent Academic Repository

COMPUTATIONAL OPTIMISATION OF TARGETED DNA SEQUENCING FOR CANCER DETECTION

EFORT Instructional Course

Hepatitis C virus and non-hodgkin s lymphoma: findings from the Swiss HIV Cohort Study

Fundamentals in Vascular Surgery

CON: Removal of the Breast Primary in Patients with Metastatic Breast Cancer

State of the Art Symposium

Integrated care : Medical Home and HMO model

Munich Cancer Registry

Munich Cancer Registry

Fundamentals in Vascular Surgery

Extract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008

Downloaded from:

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009

Exposure to source-specific transportation noise levels and temporal noise characteristics in association with arterial stiffness

Measuring and predicting cancer incidence, prevalence and survival in Finland

Hepatitis C in a sample of pregnant women in Switzerland: seroprevalence and sociodemographic factors

Medical Costs per QALY of Statins Using SMB assumptions SGIM Annual Meeting 2015 (FM277): M. Romanens et al /

Transcription:

Recent improvement of survival after breast cancer in Switzerland Pierre Pury Association Suisse des Registres des Tumeurs

Survival estimates using Cohort and Period methods for analysis, and several available softwares

Survival estimates methods and softwares Ederer Cohort Estève

Survival estimates methods and softwares Cohort Ederer Surv Surv Estève

Survival estimates methods and softwares Cohort Ederer Estève Surv Surv Relsurv Hédelin

Survival estimates methods and softwares Cohort Period Ederer Estève Surv Period (SAS( SAS) Brenner Surv Periodh (SAS( SAS) Relsurv Hédelin Brenner

Survival estimates methods and softwares Cohort Period Ederer Estève Surv Period (SAS( SAS) Brenner Surv Periodh (SAS( SAS) Brenner Relsurv Strelperiod (Stata( Stata) Hédelin Rachet

Survival estimates methods and softwares Cohort Period Ederer Surv Period (SAS,( Brenner Stata) Surv Periodh (SAS( SAS, Brenner Stata) Estève Relsurv Strelperiod (Stata( Stata) Hédelin Rachet

Survival estimates methods and softwares Cohort Period Ederer Estève Surv Period (SAS( SAS, Stata) Brenner Surv Periodh (SAS( SAS, Stata) Brenner Relsurv Strelperiod (Stata( Stata) Hédelin Rachet

Survival estimates methods and softwares Cohort Period Ederer Estève Surv Period (SAS( SAS, Stata) Brenner Surv Periodh (SAS( SAS, Stata) Brenner Strelperiod Relsurv Strelperiod (Stata( Stata) Hédelin Rachet Rachet

Survival estimates methods and softwares Cohort Period Estève Surv Periodh (Stata( Stata) Brenner Co-Hak Pe-Bre Strelperiod Strelperiod (Stata( Stata) Rachet Co-Rac Rachet Pe-Rac

Survival estimates selection of data

Survival estimates selection of data 1983-1988- 1993-1997 1997 1998-2002 Cohort Select on incidence

Survival estimates selection of data 1983-1988- 1993-1997 1997 1998-2002 Period Select on follow-up Cohort Select on incidence

Survival estimates selection of data 1983-1988- 1993-1997 1997 1998-2002 Period 2 Select on follow-up Cohort Select on incidence Period 1 Select on follow-up

100 1/ Comparing softwares and methods for crude survival Pe2-Bre

100 1/ Comparing softwares and methods for crude survival Pe2-Bre Pe1-Bre

100 1/ Comparing softwares and methods for crude survival Pe2-Bre Co-Hak Pe1-Bre

100 1/ Comparing softwares and methods for crude survival Pe2-Rac Pe1-Rac

100 1/ Comparing softwares and methods for crude survival Pe2-Rac Co-Rac Pe1-Rac

100 1/ Comparing softwares and methods for crude survival Pe2-Rac Pe2-Bre Co-Rac Co-Hak Pe1-Rac Pe1-Bre

100 2/ Comparing softwares and methods for relative survival Pe2-Bre Pe1-Bre

100 2/ Comparing softwares and methods for relative survival Pe2-Bre Co-Hak Pe1-Bre

100 2/ Comparing softwares and methods for relative survival Pe2-Rac Pe1-Rac

100 2/ Comparing softwares and methods for relative survival Pe2-Rac Co-Rac Pe1-Rac

100 2/ Comparing softwares and methods for relative survival Pe2-Rac Pe2-Bre Co-Rac Co-Hak Pe1-Rac Pe1-Bre

430 000 hab. 420 000 hab. 310 000 hab. Association suisse des registres des tumeurs www.asrt.ch

3/ Comparing relative survival of breast cancer in 3 cantons: Geneva 100 87.0% 81.5% 78.2% 67.4% Pe2-Bre Pe1-Bre

3/ Comparing relative survival of breast cancer in 3 cantons: Geneva 100 Pe2-Bre Co-Hak Pe1-Bre

3/ Comparing relative survival of breast cancer in 3 cantons: Basle 100 86.8% 76.3% Pe2-Bre.3% 68.3% Pe1-Bre

3/ Comparing relative survival of breast cancer in 3 cantons: Basle 100 Pe2-Bre Co-Hak Pe1-Bre

3/ Comparing relative survival of breast cancer in 3 cantons: Ticino 100 83.6% Pe2-Bre Pe1-Bre

3/ Comparing relative survival of breast cancer in 3 cantons: Ticino 100 Pe2-Bre Co-Hak Pe1-Bre

100 3/ Comparing relative survival of breast cancer in 3 cantons: Period 2 Geneva Basle Ticino

The Period method in conclusion - Topical short survival figures - Long survival also available - Estimations possible without delay - Recent increase of survival highlighted Many thanks to: Jean-Michel Lutz & Julian Gree Swiss network of registries Christine Bouchardy Registry of Geneva Gernot Jundt Registry of Basel Andrea Bordoni Registry of Ticino Association Suisse des Registres des Tumeurs www.asrt.ch

2024 © healthdocbox.com Privacy Policy | Terms of Service | Feedback